combined-vs-single-fgsea-simplified.html

syn68792762

Created By Sasha Scott Sasha.scott

studyId: syn53604892
studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment
initiative: Other
fundingAgency: Other

combined-vs-single-fgsea-simplified.html page is loading…